Evidence map›Paper›PMID 33036415›Full record

ArticleInternational journal of molecular sciences2020

Muhamad Ansar, Chun-Jung Wang, Yu-Han Wang, Tsung-Hua Shen, Chin-Sheng Hung, Shih-Ching Chang, Ruo-Kai Lin

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. TGFβ in Pancreas and Colorectal Cancer: Opportunities to Overcome Therapeutic Resistance.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. [MiR-671-5p negatively regulates SMAD3 to inhibit migration and invasion of osteosarcoma cells].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2021
    Article
  14. Review
  15. Article
  16. Article
  17. Recurrent Superenhancer of the OncogeneBioMed research international · 2021
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Muhamad AnsarPh.D. Program in the Clinical Drug Development of Herbal Medicine, Taipei Medical University, Taipei 110301, Taiwan.
Chun-Jung WangSchool of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 110301, Taiwan.
Yu-Han WangSchool of Medicine, Tzu Chi University, Hualien City 970374, Taiwan.
Tsung-Hua ShenSchool of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 110301, Taiwan.
Chin-Sheng HungDepartment of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110301, Taiwan.ORCID 0000-0002-9515-2036
Shih-Ching ChangDivision of Colon and Rectal Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei 112201, Taiwan.ORCID 0000-0003-4947-2546
Ruo-Kai LinPh.D. Program in the Clinical Drug Development of Herbal Medicine, Taipei Medical University, Taipei 110301, Taiwan.ORCID 0000-0002-5153-0824
Taipei Medical University · TWTaipei Medical University Hospital · TWTaipei Medical University-Shuang Ho Hospital · TWTaipei Veterans General Hospital · TWTzu Chi University · TW

Funding

Ministry of Education (Republic of China) 108-5804-001-400Ministry of Science and Technology (Republic of China) MOST104-2320-B-038-051-MY3Ministry of Science and Technology (Republic of China) MOST108-2320-B-038-020
6 · The paper itself

Abstract

The incidence and mortality rates of colorectal cancer (CRC) have been high in recent years. Prevention and early detection are crucial for decreasing the death rate. Therefore, this study aims to characterize the alteration patterns of mothers against decapentaplegic homolog 3 (

Indexed as

Biomarkers, TumorDNA MethylationCirculating Tumor DNAColorectal NeoplasmsComputational BiologyEarly Detection of CancerEpigenesis, GeneticHumansKaplan-Meier EstimateOpen Reading FramesOrgan SpecificityPrognosisPromoter Regions, GeneticRNA, MessengerSmad3 ProteinTaiwanBiomarkers, TumorCirculating Tumor DNARNA, MessengerSmad3 ProteinSMAD3 protein, humanbiomarkercirculating cell-free DNA (ccfDNA)colorectal cancer (CRC)DNA methylationearly detectionhypomethylationMothers Against Decapentaplegic Homolog 3 (SMAD3)

Identifiers

PMID33036415
PMCPMC7582763
OpenAlexW3092500085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.